Inactive Instrument

BioLife Solutions, Inc. Share Price OTC Bulletin Board

Equities

BLFS

US09062W1053

Medical Equipment, Supplies & Distribution

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for BioLife Solutions, Inc.
Sales 2024 * 109M 8.65B Sales 2025 * 122M 9.61B Capitalization 987M 78.09B
Net income 2024 * -25M -1.98B Net income 2025 * -15M -1.19B EV / Sales 2024 * 9.03 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 8.13 x
P/E ratio 2024 *
-38.3 x
P/E ratio 2025 *
-66.1 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.04%
More Fundamentals * Assessed data
Managers TitleAgeSince
Founder 52 31/12/97
Chief Executive Officer 63 03/03/16
Director of Finance/CFO 39 31/12/14
Members of the board TitleAgeSince
Chief Executive Officer 63 03/03/16
Director/Board Member 62 17/11/13
Director/Board Member 62 31/08/22
More insiders
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.
Calendar
Related indices
More about the company